Erratum to: Uric acid in the early risk stratification of ST-elevation myocardial infarction (Internal and Emergency Medicine, (2012), 7, 1, (33-39), 10.1007/s11739-011-0515-9);Uric acid in the early risk stratification of ST-elevation myocardial infarction

Internal and Emergency Medicine

Volumn 7, Issue 1, 2012, Pages 33-39

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Picariello, Claudio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Percutaneous coronary intervention; Risk stratification; ST elevation myocardial infarction; Uric acid

Indexed keywords

EID: 84856222612     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-016-1556-x     Document Type: Erratum

References (27)

1. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821.
2. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40: 437-442.
3. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190.
4. Kang D (2010) Potential role of uric acid as a risk factor for cardiovascular disease. Korean J Internal Med 25: 18-20.
5. Gagliardi AC, Miname MH, Santos RD (2009) Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202(1): 11-17.
6. Strazzullo P, Puig JG (2007) Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 17(6): 409-414.
7. Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29(3): 635-639.
8. Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34(8): 1951-1956.
9. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D et al (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107(15): 1991-1997.
10. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G et al (2002) Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89(1): 12-17.
11. Nadkar MY, Jain VI (2008) Serum uric acid in acute myocardial infarction. J Assoc Physicians India 56: 759-762.
12. Homayounfar S, Ansari M, Kashani KM (2007) Evaluation of independent prognostic importance of hyperuricemia in hospital death after acute myocardial infarction. Saudi Med J 28(5): 759-761.
13. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S et al (2005) Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96: 489-495.
14. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers A single center experience. Int J Cardiol 138: 206-216.
15. Celik T, Iyisoy A (2009) Uric acid levels for the prediction of prognosis in patients with acute ST elevation myocardial infarction: a new potential biomarker. In J Cardiol. doi: 10. 1016/j. ijcard. 2008. 12. 073.
16. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1): 84-89.
17. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 28(20): 2525-2538.
18. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Int Emerg Med (Epub ahead of print).
19. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Int Emerg Med (Epub ahead of print).
20. Lazzeri C, Valente S, Chiostri M, Picariello C and Gensini GF (2010) In hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Card Prev Rehab (in press).
21. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis. Int Emerg Med 5(1): 61-66.
22. Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352(9129): 670-671.
23. Kanellis J, Watanabe S, Li JH, Kang DH, Li P et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6): 1287-1293.
24. Ferroni P, Basili S, Paoletti V, Davì G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16(3): 222-233.
25. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11(32): 4145-4151.
26. Zweier JL, Kuppusamy P, Lutty GA (1988) Measurement of endothelial cell free radical generation: evidence for a central mechanisms of free radical injury in post ischemic tissue. Proc Natl Acad Sci 85: 4046-4050.
27. Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67: 1739-1742.